Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy

In this study, we investigated serum epidermal growth factor (EGF) in an oncological population of head- and neck and pulmonary neoplasms and whether serum EGF could serve as a prognostic marker of survival and as a predictive marker for treatment response to platinum-based chemotherapy. A total of...

Full description

Bibliographic Details

Published in:	PloS one 2021-06, Vol.16 (6), p.e0252646-e0252646
Main Authors:	Geens, Margot, Stappers, Sofie, Konings, Heleen, De Winter, Benedicte Y, Specenier, Pol, Van Meerbeeck, Jan P, Verpooten, Gert A, Abrams, Steven, Janssens, Annelies, Peeters, Marc, Van de Heyning, Paul, Vanderveken, Olivier M, Ledeganck, Kristien J
Format:	Article
Language:	eng
Subjects:	Analysis Bioinformatics Biological activity Biological markers Biology and Life Sciences Biomarkers Cancer Cell migration Chemotherapy Clinical medicine Complications and side effects Computer programs Data analysis Editing Endothelial cells Epidermal growth factor Fibroblasts Gastroenterology Global health Growth factors Head & neck cancer Head and neck cancer Health aspects Health sciences Hospitals Lungs Medical prognosis Medicine Medicine and Health Sciences Methodology Mortality Neurosciences Oncology Oncology, Experimental Otolaryngology Patient outcomes Patients Pediatrics Performance prediction Platinum Public health Questionnaires Software Surgery Thorax Translation Tumors
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!